ARV Procurement Working Group

Our Contacts

Business Online, Newyork, 1st block
1234 Building no 8, floor 3

Email: info@consultaid.com
Phone: 5586 554 558

APWG supports the ARV market in low- and middle-income countries through procurement, strategically managed demand and reduced fragmentation.‚Äč

Lopinavir/Ritonavir 40/mg/10mg Pellets and Granules


Due to the increasing uptake of paediatric LPV/r formulations, the ARV Procurement Working Group (APWG) has developed the below dashboard to provide information on supply availability in the coming 18-months.

Recommendations for country programs:

 

  • Countries are strongly discouraged from stockpiling LPV/r oral pellets or oral granules and instead advised to plan for more frequent, staggered small deliveries of large orders;
  • Available supply is expected to increase towards the end op 2019, till that time countries are encouraged to plan for a six to nine months delivery lead time from order placement to delivery;
  • Closely monitor the rate of LPV/r oral pellet or oral granule uptake and update forecasts on a frequent basis;
  • Develop clear eligibility criteria which prioritizes paediatric formulations for the appropriate populations. Current recommendation for children >10kg who can swallow should be transitioned to the 100/25mg tablets;
  • More info: https://www.arvprocurementworkinggroup.org/public/componenti/1395/files/APWGLPVrMemotoSuppliersandCountries_Jan2019.pdf

Lopinavir/Ritonavir 40/mg/10mg Pellets and Granules supply availability

image-176
image-428

Procurement and Delivery Planning Guide

image-901
Create a website